Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

October 3, 2024
BioUtah News
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]

October 3, 2024
Policy News
BioUtah and Coalition of Patient Advocates Talk PBM Reform with U.S. Reps. Blake Moore and Celeste Maloy

BioUtah’s VP for Government Affairs, Denise Bell, along with a coalition of patient advocates, life sciences executives, pharmacists, physicians, oncologists, and community organizations, held a lunch meeting with Representatives Blake Moore (R-UT) and Celeste Maloy (R-UT) October 1 to discuss the dangers of giving pharmacy benefit managers (PBMs) command over how much patients pay for […]

September 19, 2024
BioUtah News
BioUtah Member BBQ Recap

BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]

September 5, 2024
Policy News
UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.

September 5, 2024
BioUtah News
BD Completes Acquisition of Critical Care from Edwards Lifesciences

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.

September 5, 2024
BioUtah News
Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.

September 5, 2024
BioUtah News
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.

September 5, 2024
BioUtah News
FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Edwards Lifesciences announced the results from the RHEIA Trial.

September 5, 2024
BioUtah News
Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

Halia Therapeutics’ CEO, David Bearss, recently discussed the FDA’s Project Optimus in The Wall Street Journal.

August 27, 2024
BioUtah News
ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

SPRINGVILLE, UT, UNITED STATES, August 26, 2024 /EINPresswire.com/ — ATL Technology, a global leader in medical device development and manufacturing, announced today its acquisition of MDCM Solutions, a Minnesota manufacturing company specializing in complex catheter technologies used in the manufacture of minimally invasive medical devices. The newly acquired ATL Minnesota site will serve as a […]

August 22, 2024
Policy News
bioMeriéux, Curza, Present to Utah Life Sciences Innovation Caucus

Utah legislators on Wednesday, August 21, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol. BioUtah President and CEO, Kelvyn Cullimore, introduced representatives from Salt Lake City-based bioMeriéux and Curza who presented before the ULSIC. Megan Kuehn, senior vice president of site operations for bioMeriéuxi, described the company’s development […]

August 22, 2024
BioUtah News
VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION […]

August 22, 2024
BioUtah News
Ultradent Announces Majority Stake in i-dental

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is announcing acquisition of Medicinos Linija UAB, known globally as “i-dental,” a renowned manufacturer and distributer of dental products headquartered in Siauliai, Lithuania. The addition of i-dental’s network and infrastructure will assist Ultradent’s ability to better serve dentists throughout the world. With i-dental […]

August 15, 2024
BioUtah News
Arieli Capital Joins Induction Bio as a Partner and Announces the Establishment of the Induction Reproductive Health Studio – IDEAS

Reproductive Healthcare Studio focused on advancing pioneering research, developing innovative technologies and building startups that aim to transform reproductive health and fertility HERZLIYA, Israel and SALT LAKE CITY, Utah, July 31, 2024 /PRNewswire/ — Induction Bio, LLC (Induction), a reproductive healthcare company, and Arieli Capital, LLC (Arieli), a multifaceted global investment firm, today announced that Arieli […]

August 15, 2024
BioUtah News
Utah Innovation Fund Invests in Purgo Scientific

Utah Innovation Fund is pleased to announce its recent investment in Purgo Scientific, a De Novo biotech firm with a mission to revolutionize treatment of surgical site infections. The Salt Lake City-based startup is Utah Innovation Fund’s seventh investment to date out of its $30M state-backed fund. “What’s unique about Purgo is their focus on […]

August 15, 2024
BioUtah News
Turner MedTech Joins the Prestigious Inc. 5000 List

Orem, Utah – August 13, 2024 Turner MedTech, a leading innovator in the medical device and biotechnology sector, is proud to announce its inclusion in the esteemed Inc. 5000 list, a hallmark of entrepreneurial success. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its […]

July 25, 2024
BioUtah News
EDWARDS LIFESCIENCES EXPANDS STRUCTURAL HEART PORTFOLIO WITH ACQUISITIONS OF JENAVALVE AND ENDOTRONIX

IRVINE, Calif.–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a […]

July 12, 2024
BioUtah News
Utah Hosts U.S. House Ways and Means Committee Field Hearing

The U.S. House Ways and Means Committee learned how lawmakers can enable and sustain innovation in life sciences from a panel of Utah witnesses at a July 12 field hearing in Salt Lake City. Witnesses included BioUtah President and CEO Kelvyn Cullimore; Kasey DeLynn Shakespear, rural health champion and parent of a rare disease patient; […]

July 2, 2024
BioUtah News
Aspen Laser and TheraLight Complete Corporate and Warehouse Expansion

LINDON, Utah, June 28, 2024 /PRNewswire/ — Aspen Laser Systems, LLC, and TheraLight, LLC, two co-owned and co-operated, privately held U.S.-based medical device companies specializing in photomedicine, completed an expansion of their corporate headquarters and warehouse in Lindon, Utah, to advance the operations and growth of the company. The expansion, completed in April 2024, adds […]

July 2, 2024
BioUtah News
Co-Diagnostics Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States

SALT LAKE CITY, July 2, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx™️️”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that use of the Company’s vector control technology will expand to the 15th U.S. state following an installation in Nevada next week. […]

July 2, 2024
BioUtah News
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today the addition of wearables industry pioneer Ken Nelson to its Board of Directors. With his extensive experience in digital health, medical devices, and remote patient monitoring, Nelson will play a crucial role in guiding Epitel’s growth as the company continues to transform […]

July 2, 2024
BioUtah News
Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what current employees say about their experience working at […]

July 2, 2024
BioUtah News
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million. EndoGastric Solutions’ EsophyX® Z+ device delivers a durable, minimally invasive non-pharmacological treatment […]

June 27, 2024
BioUtah News
FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

Transformative Angioplasty Sheath Platform Compatible with a Broad Range of Off-the-Shelf PTA and PTCA Angioplasty Balloons Cleared by FDA